Cancer and intellectual disability

A meeting of two medical fields that were previously quite distinct.

Coming soon

Oncodefi National Days
Thursday 21 and Friday 22th October 2021 in Montpellier

Organised by the association Oncodéfi, in association with the ICM Val d’Aurelle Cancer Centre in Montpellier. They follow the great interest in cancers in people with intellectual disabilities during the last international symposium in 2018.

We invite you to participate in the Oncodefi 2021 National Days.

Association

It brings together doctors specialised in intellectual disability and cancer, nurses, professionals from the medico-social sector and families.

Booklets

Oncodefi has created a screening booklet as well as a booklet explaining the cancer care pathway in cancerology.

The Lucie est soigné pour un cancer booklet explains the cancer care pathway and the Monique booklet explains cancer screenings. The liaison booklet is intended for professionals in health care institutions and medico-social establishments that treat and support people with intellectual disabilities affected by cancer.

ISCAO

Iscao is a unique system in France consisting of two nurses who carry out awareness-raising activities and provide support to medical and social establishments.

Events

21-22October 2021
Oncodéfi

Oncodefi National Days

-April 2022
Other

Symposium 2022

27April 2022
Other

Oslo’s Inter-Symposium

10December 2019
Oncodéfi

The DAMA system

News blog

Others

A new Oncodefi tool available for free

The liaison booklet to facilitate communication between the oncology and medico-social teams is now available. It was developed by the ISCAO team. It is distributed

Help the association Oncodéfi

All donations are important, big or small, and will improve the treatment of cancer in people with intellectual disabilities.

Journées nationales Oncodéfi

21-22 Octobre 2021 à Montpellier

Organisées par l’association Oncodéfi, en lien avec le Centre de Lutte contre le Cancer ICM Val d’Aurelle de Montpellier. Elles font suite au grand intérêt porté aux cancers chez les personnes déficientes intellectuelles lors du dernier symposium international en 2018.